I agree with your all your comments. The recognition by Governments around the world of the cost they have to bear to support overweight people will ensure that they financially contribute to any medical forays into drug development that reduces weight issues. The potential share that RMD may obtain of the currently large, untouched portion of the total addressable sleep apnea market may smooth out any sales regression in the short-term but scientific development is an issue that needs to be watched closely as a long-term holder of this stock.
RMD Price at posting:
$24.73 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)